Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Positron emission tomography imaging of mu- and delta-opioid receptor binding in alcohol-dependent and healthy control subjects.

Weerts EM, Wand GS, Kuwabara H, Munro CA, Dannals RF, Hilton J, Frost JJ, McCaul ME.

Alcohol Clin Exp Res. 2011 Dec;35(12):2162-73. doi: 10.1111/j.1530-0277.2011.01565.x. Epub 2011 Jun 20.

2.

The relationship between naloxone-induced cortisol and delta opioid receptor availability in mesolimbic structures is disrupted in alcohol-dependent subjects.

Wand GS, Weerts EM, Kuwabara H, Wong DF, Xu X, McCaul ME.

Addict Biol. 2013 Jan;18(1):181-92. doi: 10.1111/j.1369-1600.2011.00430.x. Epub 2012 Jan 20.

3.

Association of smoking with μ-opioid receptor availability before and during naltrexone blockade in alcohol-dependent subjects.

Weerts EM, Wand GS, Kuwabara H, Xu X, Frost JJ, Wong DF, McCaul ME.

Addict Biol. 2014 Jul;19(4):733-42. doi: 10.1111/adb.12022. Epub 2012 Dec 18.

4.

Mu-opioid receptor binding measured by [11C]carfentanil positron emission tomography is related to craving and mood in alcohol dependence.

Bencherif B, Wand GS, McCaul ME, Kim YK, Ilgin N, Dannals RF, Frost JJ.

Biol Psychiatry. 2004 Feb 1;55(3):255-62.

PMID:
14744466
5.

Differences in delta- and mu-opioid receptor blockade measured by positron emission tomography in naltrexone-treated recently abstinent alcohol-dependent subjects.

Weerts EM, Kim YK, Wand GS, Dannals RF, Lee JS, Frost JJ, McCaul ME.

Neuropsychopharmacology. 2008 Feb;33(3):653-65. Epub 2007 May 9.

6.

Naloxone-induced cortisol predicts mu opioid receptor binding potential in specific brain regions of healthy subjects.

Wand GS, Weerts EM, Kuwabara H, Frost JJ, Xu X, McCaul ME.

Psychoneuroendocrinology. 2011 Nov;36(10):1453-9. doi: 10.1016/j.psyneuen.2011.03.019. Epub 2011 May 6.

7.

The relationship between naloxone-induced cortisol and mu opioid receptor availability in mesolimbic structures is disrupted in alcohol dependent subjects.

Wand GS, Weerts EM, Kuwabara H, Wong DF, Xu X, McCaul ME.

Alcohol. 2012 Sep;46(6):511-7. doi: 10.1016/j.alcohol.2012.04.006. Epub 2012 Jun 18.

8.

Opiate-induced dopamine release is modulated by severity of alcohol dependence: an [(18)F]fallypride positron emission tomography study.

Spreckelmeyer KN, Paulzen M, Raptis M, Baltus T, Schaffrath S, Van Waesberghe J, Zalewski MM, Rösch F, Vernaleken I, Schäfer WM, Gründer G.

Biol Psychiatry. 2011 Oct 15;70(8):770-6. doi: 10.1016/j.biopsych.2011.05.035. Epub 2011 Jul 29.

PMID:
21802658
9.

Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving.

Gorelick DA, Kim YK, Bencherif B, Boyd SJ, Nelson R, Copersino M, Endres CJ, Dannals RF, Frost JJ.

Biol Psychiatry. 2005 Jun 15;57(12):1573-82.

PMID:
15953495
10.

Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil.

Heinz A, Reimold M, Wrase J, Hermann D, Croissant B, Mundle G, Dohmen BM, Braus DF, Schumann G, Machulla HJ, Bares R, Mann K.

Arch Gen Psychiatry. 2005 Jan;62(1):57-64. Erratum in: Arch Gen Psychiatry. 2005 Sep;62(9):983. Braus, Dieter H [corrected to Braus, Dieter F].

PMID:
15630073
11.

[18F]Fallypride PET measurement of striatal and extrastriatal dopamine D 2/3 receptor availability in recently abstinent alcoholics.

Rominger A, Cumming P, Xiong G, Koller G, Böning G, Wulff M, Zwergal A, Förster S, Reilhac A, Munk O, Soyka M, Wängler B, Bartenstein P, la Fougère C, Pogarell O.

Addict Biol. 2012 Mar;17(2):490-503. doi: 10.1111/j.1369-1600.2011.00355.x. Epub 2011 Oct 3.

PMID:
22023291
12.

Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers.

Ray R, Ruparel K, Newberg A, Wileyto EP, Loughead JW, Divgi C, Blendy JA, Logan J, Zubieta JK, Lerman C.

Proc Natl Acad Sci U S A. 2011 May 31;108(22):9268-73. doi: 10.1073/pnas.1018699108. Epub 2011 May 16.

13.

Brain opioid receptor binding in early abstinence from alcohol dependence and relationship to craving: an [11C]diprenorphine PET study.

Williams TM, Davies SJ, Taylor LG, Daglish MR, Hammers A, Brooks DJ, Nutt DJ, Lingford-Hughes A.

Eur Neuropsychopharmacol. 2009 Oct;19(10):740-8. doi: 10.1016/j.euroneuro.2009.06.007.

PMID:
19595579
14.

PET imaging of human cardiac opioid receptors.

Villemagne PS, Dannals RF, Ravert HT, Frost JJ.

Eur J Nucl Med Mol Imaging. 2002 Oct;29(10):1385-8. Epub 2002 Aug 1.

PMID:
12271423
15.

Imaging of delta- and mu-opioid receptors in temporal lobe epilepsy by positron emission tomography.

Madar I, Lesser RP, Krauss G, Zubieta JK, Lever JR, Kinter CM, Ravert HT, Musachio JL, Mathews WB, Dannals RF, Frost JJ.

Ann Neurol. 1997 Mar;41(3):358-67.

PMID:
9066357
16.

Influence of OPRM1 Asn40Asp variant (A118G) on [11C]carfentanil binding potential: preliminary findings in human subjects.

Weerts EM, McCaul ME, Kuwabara H, Yang X, Xu X, Dannals RF, Frost JJ, Wong DF, Wand GS.

Int J Neuropsychopharmacol. 2013 Feb;16(1):47-53. doi: 10.1017/S146114571200017X. Epub 2012 Mar 8.

PMID:
22397905
17.

Brain mu-opioid receptor binding predicts treatment outcome in cocaine-abusing outpatients.

Ghitza UE, Preston KL, Epstein DH, Kuwabara H, Endres CJ, Bencherif B, Boyd SJ, Copersino ML, Frost JJ, Gorelick DA.

Biol Psychiatry. 2010 Oct 15;68(8):697-703. doi: 10.1016/j.biopsych.2010.05.003. Epub 2010 Jul 1.

18.

Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women.

Kennedy SE, Koeppe RA, Young EA, Zubieta JK.

Arch Gen Psychiatry. 2006 Nov;63(11):1199-208.

PMID:
17088500
19.

Positron emission tomography imaging of the serotonin transporter and 5-HT(1A) receptor in alcohol dependence.

Martinez D, Slifstein M, Gil R, Hwang DR, Huang Y, Perez A, Frankle WG, Laruelle M, Krystal J, Abi-Dargham A.

Biol Psychiatry. 2009 Jan 15;65(2):175-80. doi: 10.1016/j.biopsych.2008.08.034. Epub 2008 Oct 29.

20.

Imaging delta- and mu-opioid receptors by PET in lung carcinoma patients.

Madar I, Bencherif B, Lever J, Heitmiller RF, Yang SC, Brock M, Brahmer J, Ravert H, Dannals R, Frost JJ.

J Nucl Med. 2007 Feb;48(2):207-13. Erratum in: J Nucl Med. 2007 Mar;48(3):412. Bencherif, Badredin [corrected to Bencherif, Badreddine].

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk